VIRAL VACCINE

FIELD: medicine. ^ SUBSTANCE: invention relates to viral vaccines, in particular, to viral vaccines representing viral antigen or vaccine preparation mixed with the immunogenic composition comprising beta-carotene, mannitol, polyvinylpyrrolidone and polyoxydonium wherein the content of polyoxydonium...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KHAITOV RAKHIM MUSAEVICH, GORBUNOV MIKHAIL ALEKSANDROVICH, EL'SHINA GALINA ADAMOVNA, KARPOVICH LIDIJA GRIGOR'EVNA, MAJDANJUK ALEKSANDR GRIGOR'EVICH, BEKTIMIROV TAGIR ABDULAEVICH, PUCHKOVA NATAL'JA GRIGOR'EVNA, KUSLIJ ALEKSANDR GEORGIEVICH, PETROV REHM VIKTOROVICH, NIKULIN LEONID GEORGIEVICH, KALASHNIKOVA TAT'JANA VALENTINOVNA, IVANOVA AL'BERTA SERGEEVNA, JAKOVLEVA IRINA MIKHAJLOVNA, NEKRASOV ARKADIJ VASIL'EVICH, SANDAKHCHIEV LEV STEPANOVICH, MUNTJANOVA MARIJA ALEKSEEVNA, BUDANOV MIKHAIL VALENTINOVICH, BORISOVA VERA NIKOLAEVNA
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. ^ SUBSTANCE: invention relates to viral vaccines, in particular, to viral vaccines representing viral antigen or vaccine preparation mixed with the immunogenic composition comprising beta-carotene, mannitol, polyvinylpyrrolidone and polyoxydonium wherein the content of polyoxydonium is 0.04-12 mg per a dose. Proposed viral vaccines are used against hepatitis A, hepatitis B, hepatitis A and B and rabies. Invention provides enhancing immunogenicity of vaccine. ^ EFFECT: improved and valuable properties of vaccines. ^ 12 cl, 6 tbl, 6 ex